Outsourcing Drivers For Small Molecule Manufacturing
Source: Life Science Leader
By Industry Standard Research
ISR’s recent survey of small molecule outsourcers found that the majority of respondents outsource for one of two reasons: for all of their manufacturing needs, or to augment their internal manufacturing capacity. However, API outsourcers are more likely to outsource for all of their needs, while drug product outsourcers conversely are more likely to outsource to increase internal capacity. Market access and emergency situations seem to be infrequent drivers for outsourcing across all small molecule manufacturing.
VIEW THE MAGAZINE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Life Science Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more